Carregant...
The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
BACKGROUND: Citalopram is the most commonly prescribed antidepressant in Canada. Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of the QT interval has been documented. Drug interactions involving concomitant use of other medications that prolong the QT interval...
Guardat en:
| Publicat a: | Drug Healthc Patient Saf |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4547663/ https://ncbi.nlm.nih.gov/pubmed/26316822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S91046 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|